Evgen Pharma (GB:TCF) has released an update.
TheraCryf plc, a clinical-stage drug development company, has announced the sudden passing of its Chair, Dr. Sue Foden. Dr. Foden was a pivotal figure in the company, serving since 2015 and contributing significantly to its focus on oncology and neuropsychiatry. The company plans to appoint a new non-executive director soon to continue its innovative work in the biotech sector.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
